WDFY3-AS2 participated in the development and progression of oesophageal squamous cell carcinoma (ESCC) by regulating miR-2355-5p/SOCS2 axis, which suggested that WDFY3-AS2 might be an underlying predictor and novel therapeutic target for ESCC patients [44]. Here, WDFY3 is linked to esophageal squamous cell carcinoma.